Diagonal Bio

Diagonal Bio 📢 announces a partnership with Gocksta Stud 🐴, led by Anne-Sophie Thiam, to conduct a three-month pilot test , starting immediately.   This pilot test will evaluate LAMPlify's potential for rapid detection of respiratory viruses in horses , with a specific focus on EHV-1 (Equine Herpesvirus Type 1). This virus poses a significant risk in horse breeding due to its potential to cause spontaneous abortion in pregnant mares.   ➡️Read the full press release via the link:  https://lnkd.in/e3x47hFM

Diagonal Bio AB's Interim Report Q3, 2024 is now available on the company's website or via the link below: 👇🏼 https://lnkd.in/dx8dY9jd

🩺 Diagonal Bio announces a six-month pilot test of its point-of-care diagnostic platform, LAMPlify®, at the NMBU - Norwegian University of Life Sciences in Ås. The pilot, in collaboration with the Faculty of Veterinary Medicine and Biosciences, particularly the Department of Companion Animal Clinical Sciences, aims to evaluate the effectiveness and potential integration of LAMPlify® in the university's equine hospital. 🐴   👉 Read the full press release via the link: https://lnkd.in/dZ8Q4g-H

I samarbete med Svensk Galopp presenterar Diagonal Bio LAMPlify® på Jägersro 🏇 Diagonal Bio arrangerar den 7 november 2024 ett exklusivt evenemang på Jägersro, där bolaget introducerar sin diagnostikplattform, LAMPlify®, för en utvald grupp hästtränare. Under kvällen kommer bolaget att dela med sig av de senaste testresultaten från samarbetet med Köpenhamns universitet. Deltagarna får även se en live-demonstration av LAMPlify® och dess kapacitet att snabbt diagnostisera luftvägsvirus hos hästar på bara 10-15 minuter. ⏱️🐎 Cirka 70 tränare har bjudits in för att lära sig mer om LAMPlify® och dess potential inom hästvård. ➡️ Anmäl dig till föreläsningen senast 6 november på info@diagonalbio.com ➡️ Läs hela pressmeddelandet via länken: https://lnkd.in/dFJFenW3

Diagonal Bio AB announces successful results of a recent pilot study conducted by the Centre for Diagnostics - DTU Health Technology. The study evaluated the performance of the LAMPlify® assay panel for tests specific to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) type 1 and type 2, and Swine Influenza Virus (SIV), by comparing it to the gold-standard PCR (qPCR) tests. Read the full press release via the link:👇 https://lnkd.in/dPUYCr6p

Diagonal Bio AB announces that Hunneberga Horse Stable (Hunneberga Hästgård) and Tomas Hammar, showjumping trainer and CEO at Hunneberga Horse Stable, have initiated a partnership with Diagonal Bio to conduct a pilot test. The agreement is set for three months and will involve a testing program using LAMPlify® to detect respiratory viral infections in showjumping horses during upcoming competitions. The pilot will start immediately. 👉Read the full press release via the link: https://lnkd.in/dWSn2nG8

Diagonal Bio has partnered with StallZet and renowned trainer Daniel Redén to pilot LAMPlify® for detecting respiratory viral infections in horses 🏇. The three-month pilot aims to deliver faster and more accurate diagnostics, benefiting over 190 horses at StallZet 🐴. With StallZet's extensive national and international network in the trotter and racehorse segment, this collaboration provides Diagonal Bio a unique opportunity to expand LAMPlify®'s reach both in Sweden and globally.   "I see a huge opportunity for the entire horse industry, including different associations internationally, to start using LAMPlify® to identify sick horses before entering racetracks or arenas and to isolate them at home to prevent further infections." – Daniel Redén, trainer at StallZet   Read the full press release here: https://lnkd.in/ebQWYNZg

Diagonal Bio AB announces that its diagnostic tool, LAMPlify® has undergone a successful external validation by the University of Copenhagen. An ISO 17025 accredited laboratory performed the validation, confirming that LAMPlify® is as reliable as established real-time PCR (qPCR) methods for the detection of respiratory viruses in horses, including equine herpesvirus 1 (EHV-1) and equine herpesvirus 4 (EHV-4). The validation showed 100% correlation between LAMPlify® and qPCR tests.✅ The report also emphasized the test's user-friendliness and simplicity, underscoring Diagonal Bio's commitment to offering diagnostic solutions that combine high accuracy with speed and ease of use.💡 Read the full press release in the link below: https://lnkd.in/djz4zdQv

Diagonal Bio AB (publ) has secured an order worth just over 210,000 SEK from the DTU - Technical University of Denmark for the fish farm health project HURTIGFISK. The order includes Diagonal Bio's diagnostic instrument LAMPlify®, consumables, and consulting services. The project aims to revolutionize disease monitoring in fish farms through point-of-care diagnostics.🐟🔬 Read the full press release at the link below: https://lnkd.in/ddWCZjb4

Diagonal Bio AB's Second Quarter Report is now available on the company's website or via the link below: 👇🏼 https://lnkd.in/duv2ryWp